Bicycle Therapeutics (BCYC) Change in Accured Expenses (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Change in Accured Expenses data on file, last reported at -$597000.0 in Q2 2026.

• Quarterly Change in Accured Expenses fell 106.5% year-over-year to -$597000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $171000.0 (down 98.8% YoY) and the FY2025 annual result came in at $4.1 million, down 57.8% from the prior year.
• Change in Accured Expenses climbed to -$597000.0 in Q2 2026, from -$2.4 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $11.5 million in Q2 2023 to a low of -$8.2 million in Q1 2025.
• A 5-year average of $1.4 million and a median of $1.5 million in 2024 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 2687.8% — and 2023, when it slumped 202.01%.
• Tracing BCYC's Change in Accured Expenses over 5 years: stood at $6.9 million in 2022, then slumped by 153.68% to -$3.7 million in 2023, then soared by 201.63% to $3.7 million in 2024, then sank by 46.61% to $2.0 million in 2025, then sank by 129.85% to -$597000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$597000.0 (Q2 2026), -$2.4 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.